Does Cilostazol Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- CILOSTAZOL (> 50 MG)/STRONG & MOD 3A4 INHIB THAT PROLONG QT
- CILOSTAZOL (> 50 MG)/STRONG & MOD 2C19 INHIB THAT PROLONG QT
- CILOSTAZOL (>50MG)/SLT STRONG & MODERATE CYP3A4 INHIBITORS
- CILOSTAZOL (> 50MG)/SLT STRONG & MODERATE CYP2C19 INHIBITORS
- CILOSTAZOL (> 50 MG)/LONAFARNIB
- CILOSTAZOL (> 50 MG)/FLUOXETINE; FLUVOXAMINE
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (> 5 MG)
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30 MG)
- ANTICOAGULANT;ANTIPLATELET;THROMBOLYTIC/ALIPOGENE TIPARVOVEC
- QT PROLONGING AGENTS/ANAGRELIDE
- QT PROLONGING AGENTS/DOMPERIDONE
- QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- QT PROLONGING AGENTS/DISOPYRAMIDE
- QT PROLONGING AGENTS/CISAPRIDE
- QT PROLONGING AGENTS/SERTINDOLE
- QT PROLONGING AGENTS/DROPERIDOL
- QT PROLONGING AGENTS/LEVOMETHADYL
- QT PROLONGING AGENTS/SPARFLOXACIN
- QT PROLONGING AGENTS/HALOFANTRINE
- QT PROLONGING AGENTS/PIMOZIDE
- QT PROLONGING AGENTS/BEPRIDIL
- ANTICOAGULANTS; ANTIPLATELETS/MIFEPRISTONE
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PLATELET AGGREGATION INHIBITORS/NSAIDS; SALICYLATES
- CILOSTAZOL/QT PROLONGING AGENTS
- CILOSTAZOL (<= 50 MG)/LONAFARNIB
- QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- QT PROLONGING AGENTS/QUIZARTINIB
- ANTICOAGULANTS; ANTIPLATELETS/CAPLACIZUMAB
- QT PROLONGING AGENTS/PACRITINIB
- ANTIPLATELETS; ASPIRIN (> 100 MG)/ABROCITINIB
- QT PROLONGING AGENTS/PANOBINOSTAT
- QT PROLONGING AGENTS/MOBOCERTINIB
- QT PROLONGING AGENTS/FEXINIDAZOLE
- QT PROLONGING AGENTS/LEVOMEPROMAZINE
- QT PROLONGING AGENTS/PAZOPANIB
- QT PROLONGING AGENTS/SELPERCATINIB
- QT PROLONGING AGENTS/OXALIPLATIN
- CILOSTAZOL/CITALOPRAM; ESCITALOPRAM
- QT PROLONGING AGENTS/LEFAMULIN
- QT PROLONGING AGENTS/ENTRECTINIB
- QT PROLONGING AGENTS/GLASDEGIB
- ANTICOAGULANTS; ANTIPLATELETS/INOTERSEN
- WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
- QT PROLONGING AGENTS/IVOSIDENIB
- QT PROLONGING AGENTS/ENCORAFENIB
- QT PROLONGING AGENTS/LOFEXIDINE
- SELECTED INHIBITORS OF CNT OR ENT/CLADRIBINE
- QT PROLONGING AGENTS/MACIMORELIN
- ANTIPLATELETS; ASPIRIN (> 325 MG)/BETRIXABAN
- QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
- QT PROLONGING AGENTS/HYDROXYZINE
- QT PROLONGING AGENTS/PIMAVANSERIN
- QT PROLONGING AGENTS/VEMURAFENIB
- QT PROLONGING AGENTS/TELAVANCIN
- QT PROLONGING AGENTS/SORAFENIB
- QT PROLONGING AGENTS/ROMIDEPSIN
- QT PROLONGING AGENTS/ONDANSETRON
- QT PROLONGING AGENTS/LENVATINIB
- QT PROLONGING AGENTS/GADOFOSVESET
- QT PROLONGING AGENTS/EZOGABINE
- QT PROLONGING AGENTS/BEDAQUILINE
- QT PROLONGING AGENTS/OSIMERTINIB
- QT PROLONGING AGENTS/CHLORPROMAZINE
- QT PROLONGING AGENTS/CHLOROQUINE
- QT PROLONGING AGENTS/AZITHROMYCIN
- QT PROLONGING AGENTS/SOTALOL
- QT PROLONGING AGENTS/PROCAINAMIDE
- QT PROLONGING AGENTS/IBUTILIDE
- QT PROLONGING AGENTS/HYDROQUINIDINE; QUINIDINE
- QT PROLONGING AGENTS/FLECAINIDE
- ANTIPLATELETS; ASPIRIN (> 100 MG)/EDOXABAN
- QT PROLONGING AGENTS/DELAMANID
- QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
- QT PROLONGING AGENTS/DOFETILIDE
- QT PROLONGING AGENTS/QUETIAPINE
- ANTIPLATELETS; ASPIRIN (> 100 MG)/APIXABAN
- SELECTED ANTIPLATELETS; ASPIRIN (> 100 MG)/RIVAROXABAN
- QT PROLONGING AGENTS/VANDETANIB
- QT PROLONGING AGENTS/MOXIFLOXACIN
- QT PROLONGING AGENTS/PROPAFENONE
- QT PROLONGING AGENTS/QUININE
- QT PROLONGING AGENTS/ILOPERIDONE
- QT PROLONGING AGENTS/LOPINAVIR
- QT PROLONGING AGENTS/TOREMIFENE
- QT PROLONGING AGENTS/ZUCLOPENTHIXOL
- ANTIPLATELETS; ASPIRIN (> 100 MG)/DABIGATRAN
- QT PROLONGING AGENTS/PALIPERIDONE
- QT PROLONGING AGENTS/IVABRADINE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- QT PROLONGING AGENTS/AMIODARONE
- QT PROLONGING AGENTS/MESORIDAZINE
- QT PROLONGING AGENTS/THIORIDAZINE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- CILOSTAZOL (<=50MG)/STRONG & MOD 3A4 INHIB THAT PROLONG QT
- CILOSTAZOL (<=50MG)/SLT STRONG & MODERATE CYP3A4 INHIBITORS
- CILOSTAZOL (<=50MG)/STRONG & MOD 2C19 INHIB THAT PROLONG QT
- PLATELET INHIBITORS/SLT ANTICOAGS (VIT K ANTAG); HEPARINS
- CILOSTAZOL/POSSIBLE QT PROLONGING AGENTS
- CILOSTAZOL (<=50MG)/SLT STRONG & MODERATE CYP2C19 INHIBITORS
- CILOSTAZOL (<= 50 MG)/FLUOXETINE; FLUVOXAMINE
- QT PROLONGING AGENTS/ETRASIMOD
- QT PROLONGING AGENTS/GEPIRONE
- ANTIPLATELETS/LECANEMAB
- QT PROLONGING AGENTS/TUCIDINOSTAT
- SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
- ANTICOAGULANTS; ANTIPLATELETS/TISOTUMAB
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- ANTICOAGULANTS; ANTIPLATELETS/PLASMINOGEN
- QT PROLONGING AGENTS/GALANTAMINE
- ANTICOAGULANTS; ANTIPLATELETS/FRUQUINTINIB; SURUFATINIB
- ANTICOAGULANT;ANTIPLATELET;THROMBOLYTIC/ICOSAPENT ETHYL
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- CILOSTAZOL; TICLOPIDINE/SELECTED SSRIS;SNRIS
- WEAK CYP3A4 INHIBITORS/UBROGEPANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (<= 5 MG)
- MODERATE & WEAK CYP3A4 INHIBITORS THAT PROLONG QT/TACROLIMUS
- QT PROLONGING AGENTS/PITOLISANT
- QT PROLONGING AGENTS/GILTERITINIB
- QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- ANTICOAGULANTS; ANTIPLATELETS/MIFEPRISTONE (CUSHING)
- QT PROLONGING AGENTS/ERIBULIN
- SELECTED ANTICOAGULANTS; ANTIPLATELETS/IBRUTINIB
- QT PROLONGING AGENTS/PASIREOTIDE
- QT PROLONGING AGENTS/ALFUZOSIN
- QT PROLONGING AGENTS/FINGOLIMOD
- QT PROLONGING AGENTS/CLOZAPINE
- ANTICOAGULANTS; ANTIPLATELETS; THROMBOLYTICS/DROTRECOGIN
- QT PROLONGING AGENTS/LAPATINIB
- QT PROLONGING AGENTS/DASATINIB
- QT PROLONGING AGENTS/RANOLAZINE
- QT PROLONGING AGENTS/NORFLOXACIN
- QT PROLONGING AGENTS/GEMIFLOXACIN
- QT PROLONGING AGENTS/APOMORPHINE
- QT PROLONGING AGENTS/DOLASETRON
- PLATELET AGGREGATION INHIBITORS/LEPIRUDIN
- PLATELET AGGREGATION INHIBITORS/EPTIFIBATIDE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.